The Blood and Marrow Transplant Program at Northside Hospital is a collaboration between The Blood and marrow Transplant Group of Georgia (BMTGA) and Northside Hospital.
Research is a major component of the NSH-BMT Program. The high quality of our research program has been recognized by the National Institutes of Health (NIH) as demonstrated by our designation as a primary core clinical center for the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN). NSH-BMT joins only 19 other elite BMT Programs (and is the only one in the state of Georgia) in becoming a primary recipient of this competitive award and status.
The Leukemia & Lymphoma Society (LLS) and the Dana-Farber Cancer Institute has established a network of sites for clinical trial testing of innovative blood cancer therapies in community oncology settings across the country. This groundbreaking Blood Cancer Research Partnership (BCRP), dana-farber.org/BCRP, will bring clinical trials closer to where patients live and help to address one of the primary bottlenecks in the development of new cancer therapies: the need for more patients to take part in trials. NSH-BMT is one of ten sites who have been selected to participate in this prestigious partnership. Please review Cooperative Groups.
Our experienced research team includes research nurses, pharmacists experienced in the handling of investigational agents, and laboratory personnel.
At NSH-BMT your physicians and the clinical research team will offer you possible treatment option(s) including both standard of care treatment as well as potential clinical trials, providing you with the information you need to make an informed decision. To help you and your family understand what is involved in a clinical trial, the following information is available for your review, What is a Clinical Trial?